Status and phase
Conditions
Treatments
About
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
264 participants in 2 patient groups, including a placebo group
Loading...
Central trial contact
EU GSK Clinical Trials Call Center; US GSK Clinical Trials Call Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal